Значения термина synchronous liver на английском

The patient was a 73-year-old man with ascending colon cancer and synchronous liver metastases.

Conclusions: Deprived CRC patients with synchronous liver-limited metastases have worse survival than more affluent patients.

Two-stage hepatectomy with or without PVE was the standard approach in patients with synchronous liver metastases.

Hospital Episode Statistics data were used to identify those with synchronous liver-limited metastases who underwent liver resection.

Conclusions: Gastric cancer patients with a solitary synchronous liver metastasis may be good candidates for hepatic resection.

Conclusion: There is evidence of wide variation in surgical strategy in dealing with CRC and synchronous liver metastases.

Aims: This case report presents a patient with local unresectable primary rectal cancer and multiple synchronous liver metastases.

Case 1: A51-year-old male suffered from sigmoid colon cancer with synchronous liver metastases.

However, the feasibility of laparoscopic-assisted combined colon and liver resection in primary colorectal cancer with synchronous liver metastases remains unknown.

Bone metastases were significantly more frequently observed in patients with primary mediastinal tumors, yolk sac tumor histology, and synchronous liver metastases.

Aim: There is uncertainty regarding the optimal sequence of surgery for patients with colorectal cancer (CRC) and synchronous liver metastases.

Results: Among 2.4 million cancer patients, 5.14 % of cancer patients presented with synchronous liver metastases.

Results: A total of 9,958 CRC patients with synchronous liver-limited metastasis were extracted from the SEER database during 2010-2016.

Conclusions: Laparoscopic-assisted combined colon and liver resection is a feasible and safe procedure for the treatment of primary colorectal cancer with synchronous liver metastases.

Background: Resection of the rectal primary neoplasm with synchronous liver metastases (LM) is warranted, because this is the only strategy with curative potential.

The liver is the most common metastatic site of CRC with 20%-34% of patients suffering synchronous liver metastasis.